SMA

🧬 AI profile — grown from 6ic coverage SMA, or Spinal Muscular Atrophy, is a rare and often fatal genetic disorder that affects the nerve cells responsible for controlling voluntary muscle movement. The recent development involves a newborn screening test for SMA, which will enable early detection and potentially life-changing treatment options for affected infants in England. This test will allow for swift intervention and access to treatments that can significantly improve the quality of life for individuals with SMA.